Langen / Welwyn Garden City / Moscow / Nonthaburi / Wiltshire / Leiden / Tokyo / Wavre / Giesen / Kundl / Amsterdam / Jakarta / Rio de Janeiro / Agousa / Geneva / Dublin / Strasbourg / New London / Rockville / Berne / Canberra / Incheon / Atlanta / Seoul / Beijing / Cape Town / London / Brussels / /
Company
Dr V. Bogdanova / OMCL Networks / Sanofi / Pfizer / /
Country
Switzerland / Netherlands / South Africa / Thailand / France / Japan / Canada / Australia / United Kingdom / China / India / Germany / Russia / United States / South Korea / Ireland / / /
Facility
Serum Institute of India / National Institute / Thrombosis Research Centre / Potters Bar / University of California / Children's Hospital / National Institute of Allergy / National Institute of Infectious Diseases / National Institute of Food / Chapel Hill / / /
IndustryTerm
similar biotherapeutic products / manufacturing blood products / Biological products / blood products / manufacturing practices / diagnostic devices / equitable health systems / /
MedicalCondition
control disease / live attenuated influenza / BCG vaccine Diphtheria / antibodies Bordetella pertussis / influenza / RNA Hepatitis B / disease / /
Organization
World Health Organization / WHO Expert Committee / Division of Intramural Research / National Agency of Drug and Food Control / France International Generic Pharmaceutical Alliance / National Organisation for Drug Control and Research / USA Chinese Pharmacopoeia Commission / International Society on Thrombosis / Austria International Organization for Standardization / European Directorate for the Quality / China Council of Europe / France European Generic Medicines Association / Belgium European Medicines Agency / Canada International Federation of Pharmaceutical / National Institute of Food and Drug Safety Evaluation / National Institute of Allergy and Infectious Diseases / Lady's Children's Hospital / Serum Institute of India / National Institute of Infectious Diseases / USA Secretariat / England European Society of Human Genetics Dr M. Morris / University of California / San Francisco / European Department for the Quality of Medicines / Ministry of Health / Haemostasis & Thrombosis Research Centre / WHO Secretariat / Food and Drug Administration / Federal Medico-Biological Agency / National Institute for Biological Standards and Control / European Diagnostic Manufacturers Association / Division of Biological Products / National Institute for the Control of Pharmaceutical & Biological Products / International Plasma Fractionation Association / Justus Liebig Universität / Switzerland International Association of Biologicals Dr A. Eshkol / Centers for Disease Control and Prevention / USA Plasma Protein Therapeutics Association / United Nations / Switzerland International Federation of Clinical Chemistry / HealthCare / Medicines and Healthcare Products Regulatory Agency / Center for Biologics Evaluation and Research / Ministry of Public Health / /
Person
A. Sabouraud / C. Schärer / J.W. Atkins / K. Zoon / G.N. Vyas / E. Griffiths / J. Petricciani / H. Xiaoxu / Justus Liebig / M.M.F. Ahmed / A. van den Besselaar / Marcy l'Etoile / M. Morris / B. Marchlewicz / Bethesda / H. Klein / I. Hamaguchi / M. Schiestl / D. Wood / A. Homma / T.S. Morris / L.S. Slamet / S. Jadhav / M. Powell / D. Calam / P. Strengers / C. Giroud / T. Jivapaisarnpong / W.H. Gerlich / K. Mertens / I. von Hoegen / K.H. Buchheit / B. Plikaytis / T. Hancox / S. Mizusawa / C. Njue / R. Levandowski / S. Kox / J. Joung / G. Smith / M. Duchêne / M.P. Fletcher / / /